AYTU - Aytu BioPharma, Inc. Revenue Dynamics YoY (Last Twelve Months)

Graphic logo of aytubio.com (AYTU)

Year-over-year sales growth (TTM) demonstrates the impact of DEA regulations on Adzenys production volumes for Aytu BioPharma, Inc. (AYTU). This trend relies on the efficiency of the sales force and insurance coverage across states, while the absence of pediatric analogs allows for flexible pricing power. The current business trajectory on this chart confirms revenue resilience, with the indicator value reaching -8.40.

AYTU Aytu BioPharma, Inc.: Sales Growth YoY (Last Twelve Months) in the range 02/11/2024 - 11/18/2026

Aytu BioPharma Inc (AYTU) - metric breakdowns and financial figures

- share price and consensus valuation forecast:
Summary company analytics:AYTU (Aytu BioPharma Inc)
Mass-produced product of Aytu BioPharma

Aytu BioPharma, Inc. (AYTU) is developing a diversified portfolio of drugs for the treatment of chronic and pediatric pathologies. Revenue dynamics here are calculated as the daily percentage change in total income over a rolling twelve-month period. This metric strips fundamental indicators of short-term volatility, revealing the actual resilience of the business model. The analysis allows for the determination of the company's true expansion vector. By assessing the year-over-year sales trend over the last 12 months, an investor eliminates market noise.

Competitor analysis for Aytu BioPharma, Inc.

VRTX (Vertex Pharmaceuticals Inc.) - Trailing Twelve Months Sales Growth|Alnylam Pharmaceuticals - Sales Growth YoY (TTM)|Revenue Dynamics YoY (Last Twelve Months) INSM (Insmed Incorporated)|UTHR: Sales Growth YoY (TTM)|BioMarin Pharmaceutical Inc. (BMRN) - Sales Growth YoY (TTM)|Sales Growth YoY (Last Twelve Months) BridgeBio Pharma Inc|Revenue Growth YoY (Last 12 Months) BGM Group Ltd (BGM)|Sales Growth YoY (Last Twelve Months) cogentbio.com (COGT)|Revenue Growth YoY (Last 12 Months) Xeris Biopharma XERS|Sales Growth YoY (TTM) KROS (kerostx.com)|Sales Growth YoY (TTM) Arcturus Therapeutics Holdings Inc. ARCT|etonpharma.com - Sales Growth YoY (TTM)|KMDA - Sales Growth YoY (TTM)|FULC (Fulcrum Corp) - Revenue Growth YoY (Last 12 Months)|ABEO (Abeona Therapeutics, Inc.) - Sales Growth YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) mereobiopharma.com|PLX (Protalix BioTherapeutics, Inc.) - Revenue Change YoY (Last 12 Months)|Sales Growth YoY (TTM) PLRX|Sales Growth YoY (Last Twelve Months) APLT (Applied Therapeutics)|Rein Therapeutics Inc - Revenue Growth YoY (Last 12 Months)|Gelteq Limited (GELS) - Trailing Twelve Months Revenue Growth|CMMB - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Revenue Growth srxhealth.com|PLRZ (Polyrizon) - Revenue Growth YoY (Last 12 Months)|Aeterna Zentaris (AEZS) - Sales Growth YoY (TTM)|CYTH (Cyclo Therapeutics) - Sales Growth YoY (TTM)|INZY: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) RPHM|CSCI (COSCIENS Biopharma) - Revenue Dynamics YoY (Last Twelve Months)